These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33326677)

  • 1. Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis.
    Mimpen M; Muris AH; Rolf L; Gerlach O; Kuhle J; Hupperts R; Smolders J; Damoiseaux J
    Eur J Neurol; 2021 Mar; 28(3):901-909. PubMed ID: 33326677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
    Gilmore W; Lund BT; Li P; Levy AM; Kelland EE; Akbari O; Groshen S; Cen SY; Pelletier D; Weiner LP; Javed A; Dunn JE; Traboulsee AL
    J Neuroinflammation; 2020 Jun; 17(1):189. PubMed ID: 32539719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
    Front Immunol; 2018; 9():834. PubMed ID: 29867923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
    Mimpen M; Rolf L; Muris AH; Gerlach O; Poelmans G; Hupperts R; Smolders J; Damoiseaux J
    J Neuroimmunol; 2021 Apr; 353():577499. PubMed ID: 33529846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell subpopulations are associated with MRI activity in a relapsing-remitting multiple sclerosis patient cohort from Australia.
    Caruana P; Lemmert K; Ribbons K; Lea R; Lechner-Scott J
    Mult Scler; 2017 Oct; 23(11):1479-1487. PubMed ID: 28273762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
    Kürtüncü M; Yılmaz V; Akçay Hİ; Türkoğlu R; Altunrende B; Çınar SA; Ulusoy C; Gündüz T; İçöz S; Kasap M; Çalışkan Z; Ötünç G; Eraksoy M; Tüzün E
    J Neuroimmunol; 2019 Dec; 337():577065. PubMed ID: 31526917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.
    Palmeri S; Ponzano M; Ivaldi F; Signori A; Lapucci C; Casella V; Ferrò MT; Vigo T; Inglese M; Mancardi GL; Uccelli A; Laroni A
    CNS Drugs; 2022 Jan; 36(1):83-96. PubMed ID: 34894339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
    Gross CC; Schulte-Mecklenbeck A; Rünzi A; Kuhlmann T; Posevitz-Fejfár A; Schwab N; Schneider-Hohendorf T; Herich S; Held K; Konjević M; Hartwig M; Dornmair K; Hohlfeld R; Ziemssen T; Klotz L; Meuth SG; Wiendl H
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2973-82. PubMed ID: 27162345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
    Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
    Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for natural killer cells in the immunopathogenesis of multiple sclerosis.
    Kastrukoff LF; Morgan NG; Zecchini D; White R; Petkau AJ; Satoh J; Paty DW
    J Neuroimmunol; 1998 Jun; 86(2):123-33. PubMed ID: 9663557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.
    Kastrukoff LF; Morgan NG; Zecchini D; White R; Petkau AJ; Satoh J; Paty DW
    Neurology; 1999 Jan; 52(2):351-9. PubMed ID: 9932956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune regulatory effects of high dose vitamin D
    Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
    J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
    Eur J Neurol; 2017 May; 24(5):703-712. PubMed ID: 28261960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapsing-remitting multiple sclerosis patients exhibit differential natural killer functional subpopulations.
    Rodrigues Barreto I; Monteiro A; Paiva A; Fonseca AM
    Acta Neurol Belg; 2024 Apr; 124(2):603-610. PubMed ID: 38441808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of Peripheral Blood IL-37 Expression with T Lymphocytes Subsets and NK Cells in Patients with Primary Immune Thrombocytopenia].
    Chen Z; Qu W; Wang HQ; Xing LM; Wu YH; Liu ZY; Zhang Y; Liu H; Dong XF; Tao JL; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1201-1207. PubMed ID: 31418380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
    Illés Z; Kondo T; Newcombe J; Oka N; Tabira T; Yamamura T
    J Immunol; 2000 Apr; 164(8):4375-81. PubMed ID: 10754338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.
    Johnson TA; Evans BL; Durafourt BA; Blain M; Lapierre Y; Bar-Or A; Antel JP
    J Immunol; 2011 Jul; 187(1):570-9. PubMed ID: 21622858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
    Balasa R; Maier S; Voidazan S; Hutanu A; Bajko Z; Motataianu A
    CNS Neurol Disord Drug Targets; 2015; 14(6):804-10. PubMed ID: 25801840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D
    Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
    Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.